📰 **3 Biotech Stocks That Could Benefit from the Patent Cliff**

Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets

🔗 https://www.marketbeat.com/originals/3-biotech-stocks-that-could-benefit-from-the-patent-cliff/

#markets #news